Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis (original) (raw)
2018, Research and practice in thrombosis and haemostasis
This 9th Symposium on Hemostasis is an international scientific meeting held biannually in Chapel Hill, North Carolina. The meeting is in large measure the result of the close friendship between the late Dr. Harold R. Roberts of UNC Chapel Hill and Dr. Ulla Hedner of Novo Nordisk. When Novo Nordisk was developing the hemophilia therapy that would become NovoSeven, they sponsored a series of meetings to understand the basic biology and clinical applications of factor VIIa. The first meeting in Chapel Hill was held April 4-6, 2002 with Dr. Roberts as the organizer. Over the years, the conference emphasis has expanded from discussions of factor VIIa and tissue factor to additional topics in hemostasis and thrombosis. This year's meeting includes presentations by internationally renowned speakers that discuss the state-of-the-art on an array of important topics, including von Willebrand factor, engineering advances, coagulation and disease, tissue factor biology, therapeutic advance...
Related papers
OF NORTH AMERICA Coagulation 2006 : A Modern View of Hemostasis
HOW WELL DO WE REALLY UNDERSTAND COAGULATION? In the 1960s two groups proposed a waterfall or cascade model of coagulation composed of a sequential series of steps in which activation of one clotting factor led to the activation of another, finally leading to a burst of thrombin generation [1,2]. Each clotting factor was believed to exist as a proenzyme that could be converted to an active enzyme. The original cascade models were subsequently modified to include the observation that some procoagulants were cofactors and did not possess enzymatic activity. The coagulation process is now often outlined in a Y-shaped scheme, with distinct intrinsic and extrinsic pathways initiated by factor XII (FXII) and FVIIa/tissue factor (TF), respectively, as outlined in Fig. 1. The pathways converge on a common pathway at the level of the FXa/Fva (prothrombinase) complex. The coagulation complexes are generally noted to require phospholipid and calcium for their activity. This scheme was not actu...
Current Concepts of Hemostasis
Anesthesiology, 2004
The revised model of coagulation has implications for therapy of both hemorrhagic and thrombotic disorders. Of particular interest to anesthesiologists is the management of clotting abnormalities before, during, and after surgery. Most hereditary and acquired coagulation factor deficiencies can be managed by specific replacement therapy using clotting factor concentrates. Specific guidelines have also been developed for perioperative management of patients using anticoagulant agents that inhibit platelet or coagulation factor functions. Finally, recombinant factor VIIa has been used off-label as a hemostatic agent in some surgical situations associated with excessive bleeding that is not responsive to conventional therapy.
Thrombosis and Haemostasis
The Fourth Maastricht Consensus Conference on Thrombosis included the following themes. Theme 1: The “coagulome” as a critical driver of cardiovascular disease. Blood coagulation proteins also play divergent roles in biology and pathophysiology, related to specific organs, including brain, heart, bone marrow, and kidney. Four investigators shared their views on these organ-specific topics. Theme 2: Novel mechanisms of thrombosis. Mechanisms linking factor XII to fibrin, including their structural and physical properties, contribute to thrombosis, which is also affected by variation in microbiome status. Virus infection-associated coagulopathies perturb the hemostatic balance resulting in thrombosis and/or bleeding. Theme 3: How to limit bleeding risks: insights from translational studies. This theme included state-of-the-art methodology for exploring the contribution of genetic determinants of a bleeding diathesis; determination of polymorphisms in genes that control the rate of met...
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.